UTI antibiotic, Fetroja, receives FDA approval

The U.S. Food and Drug Administration today approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections (cUTI), including kidney infections caused by susceptible Gram-negative microorganisms, who have limited or no alternative treatment options. "Today's approval provides an additional treatment option for patients with ["]

The post UTI antibiotic, Fetroja, receives FDA approval appeared first on Outbreak News Today.